| pubmed-article:16546089 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16546089 | lifeskim:mentions | umls-concept:C0152036 | lld:lifeskim |
| pubmed-article:16546089 | lifeskim:mentions | umls-concept:C0178499 | lld:lifeskim |
| pubmed-article:16546089 | lifeskim:mentions | umls-concept:C0185125 | lld:lifeskim |
| pubmed-article:16546089 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:16546089 | lifeskim:mentions | umls-concept:C1527178 | lld:lifeskim |
| pubmed-article:16546089 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:16546089 | pubmed:dateCreated | 2006-3-20 | lld:pubmed |
| pubmed-article:16546089 | pubmed:abstractText | After a very long and windy road, in December of 2005 the FDA approved CTLA4Ig for the treatment of rheumatoid arthritis. Orencia is the first-in-class antagonist of CD28 costimulation. In this perspective, we discuss the science that led to CTLA4Ig development and the clinical challenges in bringing the drug from the bench to the bedside. | lld:pubmed |
| pubmed-article:16546089 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16546089 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16546089 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16546089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16546089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16546089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16546089 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16546089 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16546089 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:16546089 | pubmed:issn | 1074-7613 | lld:pubmed |
| pubmed-article:16546089 | pubmed:author | pubmed-author:TurkaLaurence... | lld:pubmed |
| pubmed-article:16546089 | pubmed:author | pubmed-author:BluestoneJeff... | lld:pubmed |
| pubmed-article:16546089 | pubmed:author | pubmed-author:St ClairE... | lld:pubmed |
| pubmed-article:16546089 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16546089 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:16546089 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16546089 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16546089 | pubmed:pagination | 233-8 | lld:pubmed |
| pubmed-article:16546089 | pubmed:dateRevised | 2006-5-17 | lld:pubmed |
| pubmed-article:16546089 | pubmed:meshHeading | pubmed-meshheading:16546089... | lld:pubmed |
| pubmed-article:16546089 | pubmed:meshHeading | pubmed-meshheading:16546089... | lld:pubmed |
| pubmed-article:16546089 | pubmed:meshHeading | pubmed-meshheading:16546089... | lld:pubmed |
| pubmed-article:16546089 | pubmed:meshHeading | pubmed-meshheading:16546089... | lld:pubmed |
| pubmed-article:16546089 | pubmed:meshHeading | pubmed-meshheading:16546089... | lld:pubmed |
| pubmed-article:16546089 | pubmed:meshHeading | pubmed-meshheading:16546089... | lld:pubmed |
| pubmed-article:16546089 | pubmed:meshHeading | pubmed-meshheading:16546089... | lld:pubmed |
| pubmed-article:16546089 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16546089 | pubmed:articleTitle | CTLA4Ig: bridging the basic immunology with clinical application. | lld:pubmed |
| pubmed-article:16546089 | pubmed:affiliation | Diabetes Center, University of California, San Francisco, San Francisco, California 94143, USA. jbluest@immunetolerance.org | lld:pubmed |
| pubmed-article:16546089 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16546089 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16546089 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16546089 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16546089 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16546089 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16546089 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16546089 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16546089 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16546089 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16546089 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16546089 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16546089 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16546089 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16546089 | lld:pubmed |
